ALISO VIEJO, Calif.--(BUSINESS WIRE)--

Ambry Genetics, a global leader in genetics with a focus on clinical diagnostics and genomic services, is sponsoring the Clinical Diagnostics Conference 2012, September 27-29 at the St. Regis Monarch Beach Resort. The event will feature a keynote speech by Kevin Davies, Ph.D., Editor-in-Chief of Bio-IT World and author of The $1,000 Genome: The Revolution in DNA Sequencing and the New Era of Personalized Medicine (Free Press, 2010), as well as a number of industry leaders and surprise guests.

As the name implies, this conference will take a close look at cutting-edge developments in clinical diagnostics and related fields, as well as insights on what comes next, from some of the leaders in the field, commented Charles Dunlop, chief executive officer of Ambry Genetics. This is the first of what we hope will become an annual event, and the speaker roster is growing fast with boldface names from around the world. We invite clinicians and anyone else with an interest in clinical diagnostics, genomics and genetics to join us at the beautiful St. Regis Monarch Beach for two days of enrichment, networking and socializing.

Conference highlights:

About Ambry Genetics

Ambry Genetics is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified commercial clinical laboratory with headquarters in Aliso Viejo, Orange County, Calif. Since its founding in 1999, it has become a leader in providing genetic services focused on clinical diagnostics and genomic services, particularly in sequencing and array services. Ambry has established a reputation for unparalleled service and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and to the advancement of disease research. To learn more about testing and services available through Ambry Genetics, visit http://www.ambrygen.com.

See the original post:
Ambry Genetics to Sponsor The Clinical Diagnostics Conference 2012: What’s Next & What’s Now

Comments are closed.